Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Gynecology

Free Subscription Articles published in Anticancer Res Retrieve available abstracts of 76 articles: HTML format Text format

Single Articles

May 2012
1. JESCHKE U , Wiest I, Schumacher AL, Kupka M, et al
   Determination of MUC1 in Sera of Ovarian Cancer Patients and in Sera of Patients with Benign Changes of the Ovaries with CA15-3, CA27.29, and PankoMab.
   Anticancer Res. 2012;32:2185-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. ENGEL JB , Hahne JC, Hausler SF, Meyer S, et al
   Peptidomimetic GnRH Antagonist AEZS-115 Inhibits the Growth of Ovarian and Endometrial Cancer Cells.
   Anticancer Res. 2012;32:2063-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. HONIG A , Hahne JC, Meyer S, Kranke P, et al
   PI3K Inhibitor D-116883 is Effective in In Vitro Models of Ovarian Cancer.
   Anticancer Res. 2012;32:2035-41.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. RANK A , Liebhardt S, Zwirner J, Burges A, et al
   Circulating microparticles in patients with benign and malignant ovarian tumors.
   Anticancer Res. 2012;32:2009-14.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. FREYDANCK MK , Laubender RP, Rack B, Schuhmacher L, et al
   Two-marker Combinations for Preoperative Discrimination of Benign and Malignant Ovarian Masses.
   Anticancer Res. 2012;32:2003-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. GONZALEZ-RODILLA I , Boix M, Verna V, Munoz AB, et al
   Patient age and biological aggressiveness of endometrial carcinoma.
   Anticancer Res. 2012;32:1817-20.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. MUALLEM MZ , Yildiz S, Arsenic R, Trefzer U, et al
   Vaginal fistula in a patient with relapsed ovarian cancer and amelanotic melanoma.
   Anticancer Res. 2012;32:1737-42.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   April 2012
8. LEE YY , Choi CH, Kim HJ, Kim TJ, et al
   Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma.
   Anticancer Res. 2012;32:1555-61.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. CAPMAS P , Billard V, Gouy S, Lhomme C, et al
   Impact of epidural analgesia on survival in patients undergoing complete cytoreductive surgery for ovarian cancer.
   Anticancer Res. 2012;32:1537-42.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. HENRIKSEN R , Dizeyi N, Abrahamsson PA
    Expression of Serotonin Receptors 5-HT1A, 5-HT1B, 5-HT2B and 5-HT4 in Ovary and in Ovarian Tumours.
    Anticancer Res. 2012;32:1361-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. MARLEAU AM , McDonald G, Koropatnick J, Chen CS, et al
    Reduction of tumorigenicity by placental extracts.
    Anticancer Res. 2012;32:1153-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2012
12. KURTZ JE , Freyer G, Joly F, Gladieff L, et al
    Combined Oral Topotecan plus Carboplatin in Relapsed or Advanced Cervical Cancer: A GINECO Phase I-II Trial.
    Anticancer Res. 2012;32:1045-1049.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. KOSKAS M , Azria E, Walker F, Luton D, et al
    Progestin Treatment of Atypical Hyperplasia and Well-differentiated Adenocarcinoma of the Endometrium to Preserve Fertility.
    Anticancer Res. 2012;32:1037-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2012
14. 
    Diagnostic pathology of ovarian tumors.
    Anticancer Res. 2012;32:715.
    PubMed     Text format     Related articles   
    
    
    
    
15. FAMBRINI M , Pieralli A, Bitossi U, Andersson KL, et al
    Mini-laparotomy versus Vaginal Surgery for Class II-III Obese Patients with Early-stage Endometrial Cancer.
    Anticancer Res. 2012;32:707-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. KIM H , Kim K, No JH, Jeon YT, et al
    Prognostic value of biomarkers related to drug resistance in patients with advanced epithelial ovarian cancer.
    Anticancer Res. 2012;32:589-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. CECCARONI M , Roviglione G, Spagnolo E, Casadio P, et al
    Pelvic Dysfunctions and Quality of Life after Nerve-sparing Radical Hysterectomy: A Multicenter Comparative Study.
    Anticancer Res. 2012;32:581-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. FEKETE M , Santiskulvong C, Eng C, Dorigo O, et al
    Effect of PI3K/Akt Pathway Inhibition-Mediated G1 Arrest on Chemosensitization in Ovarian Cancer Cells.
    Anticancer Res. 2012;32:445-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. VOMVAS D , Iconomou G, Soubasi E, Leotsinidis M, et al
    Assessment of sexual function in patients with cancer undergoing radiotherapy--a single centre prospective study.
    Anticancer Res. 2012;32:657-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2012
20. CORDES T , Hoellen F, Dittmer C, Salehin D, et al
    Correlation of Prostaglandin Metabolizing Enzymes and Serum PGE2 Levels with Vitamin D Receptor and Serum 25(OH)2D3 Levels in Breast and Ovarian Cancer.
    Anticancer Res. 2012;32:351-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. GADDUCCI A , Cosio S, Fabrini MG, Guerrieri ME, et al
    Analysis of Failures in Patients with FIGO Stage IIIc1-IIIc2 Endometrial Cancer.
    Anticancer Res. 2012;32:201-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. FABRINI MG , Gadducci A, Perrone F, LA Liscia C, et al
    Relationship between Interval from Surgery to Radiotherapy and Local Recurrence Rate in Patients with Endometrioid-type Endometrial Cancer: a Retrospective Mono-institutional Italian Study.
    Anticancer Res. 2012;32:169-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. DEQNAH N , Yu JQ, Beale P, Fisher K, et al
    Synthesis of Trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its Activity in Human Ovarian Tumour Models.
    Anticancer Res. 2012;32:135-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. NESSA MU , Beale P, Chan C, Yu JQ, et al
    Combinations of resveratrol, Cisplatin and oxaliplatin applied to human ovarian cancer cells.
    Anticancer Res. 2012;32:53-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. SALEHIN D , Haugk C, Thill M, Cordes T, et al
    Vitamin D receptor expression in patients with vulvar cancer.
    Anticancer Res. 2012;32:283-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. SALEHIN D , Haugk C, Thill M, Cordes T, et al
    Serum 25-hydroxyvitamin D levels in patients with vulvar cancer.
    Anticancer Res. 2012;32:265-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
27. MIYOSHI Y , Ueda Y, Morimoto A, Yokoyama T, et al
    Salvage chemotherapy for ovarian carcinoma recurring during or after consolidation chemotherapy with Paclitaxel.
    Anticancer Res. 2011;31:4613-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. UEDA Y , Okazawa M, Enomoto T, Egawa-Takata T, et al
    Dissection of Unsuspicious Para-aortic Lymph Nodes Does Not Improve Prognosis of Advanced Endometrial Carcinoma with Intra- or Extra-abdominal Metastasis.
    Anticancer Res. 2011;31:4513-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. CHEREAU E , Lavoue V, Ballester M, Coutant C, et al
    External Validation of a Laparoscopic-based Score to Evaluate Resectability for Patients with Advanced Ovarian Cancer Undergoing Interval Debulking Surgery.
    Anticancer Res. 2011;31:4469-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. JANSEN FH , Adoubi I, J C KC, DE Cnodder T, et al
    First study of oral artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers.
    Anticancer Res. 2011;31:4417-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. YING TH , Tseng CJ, Tsai SJ, Hsieh SC, et al
    Association of p53 and CDKN1A Genotypes with Endometriosis.
    Anticancer Res. 2011;31:4301-4306.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. YUNOS NM , Beale P, Yu JQ, Huq F, et al
    Synergism from the combination of oxaliplatin with selected phytochemicals in human ovarian cancer cell lines.
    Anticancer Res. 2011;31:4283-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. GONZALEZ-RODILLA I , Verna V, Munoz AB, Estevez J, et al
    Expression of the Apoptosis-related Genes Bcl-2 and p53 in Clinical Samples from Endometrial Carcinoma Patients.
    Anticancer Res. 2011;31:4191-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
34. GERESTEIN CG , Eijkemans MJ, Bakker J, Elgersma OE, et al
    Nomogram for suboptimal cytoreduction at primary surgery for advanced stage ovarian cancer.
    Anticancer Res. 2011;31:4043-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. MONTEIL J , Maubon A, Leobon S, Roux S, et al
    Lymph Node Assessment with 18F-FDG-PET and MRI in Uterine Cervical Cancer.
    Anticancer Res. 2011;31:3865-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. NESSA MU , Beale P, Chan C, Yu JQ, et al
    Synergism from combinations of Cisplatin and oxaliplatin with quercetin and thymoquinone in human ovarian tumour models.
    Anticancer Res. 2011;31:3789-97.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. GAO X , Liu Y, Deeb D, Arbab AS, et al
    Synthetic Oleanane Triterpenoid, CDDO-Me, Induces Apoptosis in Ovarian Cancer Cells by Inhibiting Prosurvival AKT/NF-kappaB/mTOR Signaling.
    Anticancer Res. 2011;31:3673-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
38. KASUYA G , Ogawa K, Iraha S, Nagai Y, et al
    Severe late complications in patients with uterine cancer treated with postoperative radiotherapy.
    Anticancer Res. 2011;31:3527-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. GADDUCCI A , Cosio S, Fabrini MG, Fanucchi A, et al
    Patterns of failures in endometrial cancer: clinicopathological variables predictive of the risk of local, distant and retroperitoneal failure.
    Anticancer Res. 2011;31:3483-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. IAVAZZO C , Vorgias G, Mastorakos G, Stefanatou G, et al
    Uterobrush method in the detection of endometrial pathology.
    Anticancer Res. 2011;31:3469-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. ZHANG W , Yang HC, Wang Q, Yang ZJ, et al
    Clinical value of combined detection of serum matrix metalloproteinase-9, heparanase, and cathepsin for determining ovarian cancer invasion and metastasis.
    Anticancer Res. 2011;31:3423-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. SONG K , Li J, Li L, Zhang P, et al
    Intracellular Metabolism, Subcellular Localization and Phototoxicity of HMME/HB in Ovarian Cancer Cells.
    Anticancer Res. 2011;31:3229-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
43. WATANABE Y , Hoshiai H, Nakanishi T, Kawamura N, et al
    Evaluation of Oral Etoposide in Combination with Cisplatin for Patients with Recurrent Cervical Cancer: Long-term Follow-up Results of a Japanese Multicenter Study.
    Anticancer Res. 2011;31:3063-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. KOSKAS M , Yazbeck C, Walker F, Clouqueur E, et al
    Fertility-sparing Management of Grade 2 and 3 Endometrial Adenocarcinomas.
    Anticancer Res. 2011;31:3047-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. YI BR , Kang NH, Hwang KA, Kim SU, et al
    Antitumor Therapeutic Effects of Cytosine Deaminase and Interferon-{beta} Against Endometrial Cancer Cells Using Genetically Engineered Stem Cells In Vitro.
    Anticancer Res. 2011;31:2853-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
46. PIETZNER K , Richter R, Chekerov R, Erol E, et al
    Bevacizumab in Heavily Pre-treated and Platinum Resistant Ovarian Cancer: A Retrospective Study of the North-Eastern German Society of Gynaecologic Oncology (NOGGO) Ovarian Cancer Study Group.
    Anticancer Res. 2011;31:2679-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. PIETZNER K , Schmuck RB, Fotopoulou C, Gellermann J, et al
    Long term combination treatment with bevacizumab, pegylated liposomal Doxorubicin and regional abdominal hyperthermia in platinum refractory ovarian cancer: a case report and review of the literature.
    Anticancer Res. 2011;31:2675-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. SCHROEDER JK , Kuemmel S, Pietzner K, Hector J, et al
    Optimizing the Clinical Management of Gynecological and Breast Cancer via Online Tumor Conferences.
    Anticancer Res. 2011;31:2669-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. KALAMANATHAN S , Bates V, Lord R, Green JA, et al
    The mutational profile of sporadic epithelial ovarian carcinoma.
    Anticancer Res. 2011;31:2661-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. CHEKEROV R , Braun S, Ebert AD, Herbstreit C, et al
    First evaluation of the joint clinical registry data of patients with primary ovarian cancer at the coordinating tumor center of berlin.
    Anticancer Res. 2011;31:2657-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. LANDT S , Mordelt K, Schwidde I, Barinoff J, et al
    Prognostic significance of the angiogenic factors angiogenin, endoglin and endostatin in cervical cancer.
    Anticancer Res. 2011;31:2651-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. LANDT S , Heidecke H, Reuter C, Korlach S, et al
    The utility of an in vitro angiogenesis score for prognosis assessment in patients with cervical cancer.
    Anticancer Res. 2011;31:2645-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. CIORTEA R , Costin N, Braicu I, Haragas D, et al
    Effect of Melatonin on Intra-abdominal Fat in Correlation with Endometrial Proliferation in Ovariectomized Rats.
    Anticancer Res. 2011;31:2637-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. FOTOPOULOU C , Sehouli J, Pschowski R, VON Haehling S, et al
    Systemic Changes of Tryptophan Catabolites via the Indoleamine-2,3-dioxygenase Pathway in Primary Cervical Cancer.
    Anticancer Res. 2011;31:2629-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. LANDT S , Heidecke H, Korlach S, Reuter C, et al
    In vitro vascular tube formation testing as a tool for treatment individualisation in patients with cervical cancer.
    Anticancer Res. 2011;31:2609-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. PAPANIKOLAOU G , Fotopoulou C, Braicu I, Chekerov R, et al
    First Surgical Experience of Intraperitoneal Treatment with the Trifunctional Antibody Catumaxomab (Anti-EpCam x Anti-CD3) for Epithelial Ovarian Cancer.
    Anticancer Res. 2011;31:2603-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. COLLETTINI F , Poellinger A, Schnapauff D, Denecke T, et al
    CT-Guided High-Dose-Rate Brachytherapy of Metachronous Ovarian Cancer Metastasis to the Liver: Initial Experience.
    Anticancer Res. 2011;31:2597-602.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. LANDT S , Wehling M, Heidecke H, Jeschke S, et al
    Prognostic significance of angiogenic factors in uterine cervical cancer.
    Anticancer Res. 2011;31:2589-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. GIL-IBANEZ B , Oskay-Ozcelik G, Richter R, Fotopoulou C, et al
    Predictive Factors in Relapsed Ovarian Cancer for Complete Tumor Resection.
    Anticancer Res. 2011;31:2583-2587.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
60. HIKITA S , Yotsumoto F, Fumaki T, Horiuchi S, et al
    Assessment of HB-EGF Levels in Peritoneal Fluid and Serum of Ovarian Cancer Patients using ELISA.
    Anticancer Res. 2011;31:2553-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. TSUJIOKA H , Fukami T, Yotsumoto F, Ueda T, et al
    A Possible Clinical Adaptation of CRM197 in Combination with Conventional Chemotherapeutic Agents for Ovarian Cancer.
    Anticancer Res. 2011;31:2461-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. DOHI S , Ohno S, Ohno Y, Takakura M, et al
    WT1 Peptide Vaccine Stabilized Intractable Ovarian Cancer Patient for One Year: A Case Report.
    Anticancer Res. 2011;31:2441-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
63. AMANT F , Tousseyn T, Coenegrachts L, Decloedt J, et al
    Case Report of a Poorly Differentiated Uterine Tumour with t(10;17) Translocation and Neuroectodermal Phenotype.
    Anticancer Res. 2011;31:2367-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. EGGEN T , Sager G, Arnes M, Pettersen I, et al
    Expression of iNOS - A Favourable Prognostic Marker for Early-stage Carcinoma of the Uterine Cervix.
    Anticancer Res. 2011;31:2319-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. POLTERAUER S , Grimm C, Zeillinger R, Heinze G, et al
    Association of C-Reactive Protein (CRP) Gene Polymorphisms, Serum CRP Levels and Cervical Cancer Prognosis.
    Anticancer Res. 2011;31:2259-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. HOLZER TR , Fulford AD, Arkins AM, Grondin JM, et al
    Ischemic time impacts biological integrity of phospho-proteins in PI3K/Akt, Erk/MAPK, and p38 MAPK signaling networks.
    Anticancer Res. 2011;31:2073-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
67. PRADIER C , Cornuau M, Norca J, Mesbah H, et al
    Differences in breast carcinoma in situ between menopausal and premenopausal women.
    Anticancer Res. 2011;31:1783-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
68. PYLVAS M , Puistola U, Laatio L, Kauppila S, et al
    Elevated Serum 8-OHdG Is Associated with Poor Prognosis in Epithelial Ovarian Cancer.
    Anticancer Res. 2011;31:1411-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. STANWAY SJ , Palmieri C, Stanczyk FZ, Folkerd EJ, et al
    Effect of tamoxifen or anastrozole on steroid sulfatase activity and serum androgen concentrations in postmenopausal women with breast cancer.
    Anticancer Res. 2011;31:1367-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. YOSHIDA H , Sumi T, Zhi X, Yasui T, et al
    Claudin-4: A Potential Therapeutic Target in Chemotherapy-resistant Ovarian Cancer.
    Anticancer Res. 2011;31:1271-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. YUNOS NM , Beale P, Yu JQ, Huq F, et al
    Synergism from Sequenced Combinations of Curcumin and Epigallocatechin-3-gallate with Cisplatin in the Killing of Human Ovarian Cancer Cells.
    Anticancer Res. 2011;31:1131-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. HIRAKAWA M , Nagai Y, Toita T, Kudaka W, et al
    High-risk group for locoregional recurrence in patients with stage IB-IIB squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy.
    Anticancer Res. 2011;31:1437-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
73. YELLEPEDDI VK , Kumar A, Maher DM, Chauhan SC, et al
    Biotinylated PAMAM Dendrimers for Intracellular Delivery of Cisplatin to Ovarian Cancer: Role of SMVT.
    Anticancer Res. 2011;31:897-906.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. MARKOWSKI DN , Helmke BM, Belge G, Nimzyk R, et al
    HMGA2 and p14Arf: major roles in cellular senescence of fibroids and therapeutic implications.
    Anticancer Res. 2011;31:753-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
75. WEISSENBACHER T , Kuhn C, Mayr D, Pavlik R, et al
    Expression of mucin-1, galectin-1 and galectin-3 in human leiomyosarcoma in comparison to leiomyoma and myometrium.
    Anticancer Res. 2011;31:451-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
76. BIESTERFELD S , Beckers S, Del Carmen Villa Cadenas M, Schramm M, et al
    Feulgen staining remains the gold standard for precise DNA image cytometry.
    Anticancer Res. 2011;31:53-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: